Attributable Mortality to Candidiasis in Non-Neutropenic Critically Ill Patients in the ICU and a Post-Mortem Study

Jordi Ibañez-Nolla1,2, Felip Garcia3, Miquel A Carrasco4

  • 1Health Sciences Faculty, Blanquerna-Universitat Ramon Llull, 08025 Barcelona, Spain.

PubMed

Insights

Determining mortality attributable to candidiasis in intensive care units (ICUs) is challenging. This study found that statistical methods align with post-mortem data, offering a reliable way to assess candidiasis-related deaths in critically ill patients.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Pathology

Background:

  • Candidiasis presents significant challenges in critical care settings, with difficulties in diagnosis and establishing direct causality to patient mortality.
  • Uncertainty exists regarding the direct link between candidiasis and death in patients experiencing multiorgan failure.

Purpose of the Study:

  • To validate the consistency of statistically attributable mortality for candidiasis against post-mortem attributable mortality.
  • To assess the reliability of different mortality calculation methods for invasive candidiasis.

Main Methods:

  • A prospective study involving non-neutropenic intensive care unit (ICU) patients with detected Candida.
  • Invasive candidiasis was defined by evidence of disseminated or multifocal infection.
  • Post-mortem studies served as the gold standard, compared with clinical and statistical mortality assessments.

Main Results:

  • Post-mortem attributable mortality was 30.6%, while clinical study assessment yielded 22.6%.
  • Statistically attributable mortality was 25% relative to overall ICU mortality and 27% relative to Candida colonization.
  • Calculations for attributable mortality, whether statistical or crude death rate, showed agreement for Candida-related deaths.

Conclusions:

  • Statistical and post-mortem methods for determining candidiasis-attributable mortality are consistent.
  • Implementing these metrics can potentially enhance ICU outcomes for non-neutropenic critically ill patients with candidiasis.